PHK
ORIC icon

Point72 Hong Kong’s Oric Pharmaceuticals ORIC Stock Holding History

Point72 Hong Kong’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,432
Closed -$5K – 1219
2022
Q3 		$5K Buy
1,432
+1,322
+1,202% +$5.29K ﹤0.01% 1790
2022
Q2 		$0 Sell
110
-4,422
-98% -$17.6K ﹤0.01% 2289
2022
Q1 		$24K Buy
+4,532
New +$40.8K ﹤0.01% 1498
2021
Q3 		– Sell
-1,895
Closed -$34K – 2325
2021
Q2 		$34K Buy
+1,895
New +$41.5K ﹤0.01% 1549

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Point72 Hong Kong's ORIC Position: Q4 2022 in Review

Point72 Hong Kong sold out of Oric Pharmaceuticals (ORIC) in Q4 2022, closing a stake of 1,432 shares — an estimated $5K sold.

Point72 Hong Kong first reported a position in ORIC in Q2 2021 and held it in 4 quarters. The position peaked at $34K in Q2 2021. 65 funds tracked by Wall St. Rank hold ORIC as of Q4 2022.

  • Point72 Hong Kong reported no remaining Oric Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,432 Oric Pharmaceuticals shares in Q4 2022, an estimated $5K.
  • Point72 Hong Kong first reported a position in Oric Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Point72 Hong Kong's Oric Pharmaceuticals position peaked at $34K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.